Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Lipid Biosynthesis Inhibitors

Santa Cruz Biotechnology now offers a broad range of lipid biosynthesis inhibitors for use in various applications. Lipid biosynthesis inhibitors are essential tools in scientific research for studying the complex pathways involved in lipid metabolism. These inhibitors target key enzymes in lipid biosynthetic pathways, such as fatty acid synthase, acetyl-CoA carboxylase, and HMG-CoA reductase, among others. By blocking these enzymes, researchers can dissect the role of lipid synthesis in cellular processes and understand how disruptions in these pathways contribute to metabolic disorders, cancer, and other diseases. Lipid biosynthesis inhibitors are used to explore the regulation of lipid homeostasis, the impact of lipid metabolites on cell signaling, and the mechanisms underlying lipid-related diseases. They are also crucial in the development of strategies aimed at controlling lipid levels in the body. By providing a comprehensive selection of high-quality lipid biosynthesis inhibitors, Santa Cruz Biotechnology supports advanced research in biochemistry and cell biology. These products empower scientists to conduct precise and reproducible experiments, driving innovations in our understanding of lipid metabolism and the development of new standards for lipid-associated conditions. View detailed information on our available lipid biosynthesis inhibitors by clicking on the product name.

Items 11 to 14 of 14 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

URB-754

86672-58-4sc-200671
sc-200671A
10 mg
50 mg
$80.00
$240.00
(0)

URB-754 is an influential compound in lipid biosynthesis, primarily functioning as a selective modulator of diacylglycerol acyltransferase (DGAT). By binding to the enzyme's active site, it alters substrate affinity and enzymatic efficiency, thereby impacting triglyceride synthesis. Its unique hydrophobic interactions enhance membrane fluidity, while its ability to form transient complexes with lipid intermediates can redirect metabolic flux, ultimately influencing cellular lipid homeostasis.

Difluoro Atorvastatin

693794-20-6sc-394113
5 mg
$360.00
(0)

Difluoro Atorvastatin plays a pivotal role in lipid biosynthesis by selectively inhibiting HMG-CoA reductase, a key enzyme in the mevalonate pathway. Its unique fluorinated structure enhances binding affinity, promoting a conformational change that stabilizes the enzyme-substrate complex. This alteration in reaction kinetics effectively reduces cholesterol synthesis. Additionally, its lipophilic nature facilitates integration into lipid membranes, influencing membrane dynamics and cellular signaling pathways.

Triacsin C, lyophilized

76896-80-5sc-477680
sc-477680A
200 µg
1 mg
$408.00
$1362.00
3
(0)

Triacsin C is a potent inhibitor of acyl-CoA synthetase, disrupting lipid biosynthesis by preventing the activation of fatty acids. Its unique structure allows for specific interactions with the enzyme's active site, leading to altered substrate availability and metabolic flux. This inhibition affects various lipid metabolic pathways, influencing the synthesis of complex lipids. The compound's stability in lyophilized form enhances its utility in biochemical studies, providing insights into lipid metabolism regulation.

N-[3,5-Bis(decyloxy)phenyl]-N-(carboxymethyl)glycine

153125-17-8sc-507222
25 mg
$1310.00
(0)

N-[3,5-Bis(decyloxy)phenyl]-N-(carboxymethyl)glycine plays a significant role in lipid biosynthesis by modulating lipid metabolism pathways. Its unique molecular structure facilitates interactions with key enzymes involved in fatty acid synthesis, enhancing reaction kinetics. The compound's hydrophobic decyloxy groups promote membrane integration, influencing lipid bilayer dynamics and stability. This interaction can lead to altered lipid profiles, impacting cellular functions and signaling pathways.